Synaptogenix Inc

General ticker "SNPX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.7M

Synaptogenix Inc does not follow the US Stock Market performance with the rate: -40.4%.

Estimated limits based on current volatility of 5.2%: low 2.70$, high 2.99$

Factors to consider:

  • Current price 18.4% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.60$, 12.39$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.38$, 7.49$]

Financial Metrics affecting the SNPX estimates:

  • Negative: Non-GAAP EPS, $ of -41.37 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -62.70 <= 2.35
  • Negative: negative Net income
  • Negative: Investing cash flow per share, $ of -4.30 <= -3.48
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term SNPX quotes

Long-term SNPX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.01MM $2.16MM $0.00MM
Operating Expenses $12.62MM $7.73MM $8.31MM
Operating Income $-12.61MM $-5.57MM $-8.31MM
Non-Operating Income $0.00MM $0.00MM $2.28MM
R&D Expense $4.34MM $6.32MM $1.97MM
Income(Loss) $-12.61MM $-5.57MM $-6.04MM
Profit(Loss) $-12.61MM $-5.57MM $-6.04MM
Stockholders Equity $33.53MM $32.69MM $24.35MM
Assets $35.52MM $38.61MM $31.11MM
Operating Cash Flow $-8.71MM $-11.21MM $-5.17MM
Capital expenditure $0.00MM $0.01MM $0.00MM
Investing Cash Flow $-0.00MM $-0.01MM $-2.00MM
Financing Cash Flow $37.13MM $14.48MM $-1.64MM
Earnings Per Share* $-2.51 $-0.78 $-29.56

* EPS are Split Adjusted, recent splits may be reflected with a delay.